Risperdal Consta will be the first LONG-ACTING injectable ATYPICAL antipsychotic

Risperdal Consta will be the first LONG-ACTING injectable ATYPICAL antipsychotic.

Patients who don't take oral meds consistently can now get a shot every 2 weeks.

Risperdal Consta will come in 25, 37.5, and 50 mg vials.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote